Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Alfuzosin hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alfuzosin 10mg modified-release tablets
0704010A0AAADAD
|
Alfuzosin hydrochloride | Alfuzosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 78,775 |
|
Alfuzosin 2.5mg tablets
0704010A0AAAAAA
|
Alfuzosin hydrochloride | Alfuzosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 24,156 |
|
Alfuzosin 10mg/5ml oral suspension
0704010A0AAAHAH
|
Alfuzosin hydrochloride | Alfuzosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Alfuzosin 10mg/5ml oral solution
0704010A0AAAFAF
|
Alfuzosin hydrochloride | Alfuzosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Alfuzosin 5mg modified-release tablets
0704010A0AAABAB
|
Alfuzosin hydrochloride | Alfuzosin hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.